Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1656, 2008-01, pp. : 22-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PML with rituximab during RA treatment
Reactions Weekly, Vol. 1, Iss. 1220, 2008-01 ,pp. :
Access to resources
Recommend
Rituximab may contribute to the development of progressive multifocal leukoencephalopathy (PML)
Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. :
Rituximab reduces joint damage in RA patients
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Rituximab benefits difficult-to-treat patients with RA
Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. :
Rituximab gives standard RA therapies a run for their money
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. :